Cargando…
A short account of metastatic bone disease
In adults, bone is the preferential target site for metastases from primary cancers of prostate, breast, lungs and thyroid. The tendency of these cancers to metastasize to bone is determined by the anatomical distribution of the blood vessels, by the genetic profile of the cancer cells and by the bi...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3160351/ https://www.ncbi.nlm.nih.gov/pubmed/21794164 http://dx.doi.org/10.1186/1475-2867-11-24 |
_version_ | 1782210542082981888 |
---|---|
author | Feller, Liviu Kramer, Beverley Lemmer, Johan |
author_facet | Feller, Liviu Kramer, Beverley Lemmer, Johan |
author_sort | Feller, Liviu |
collection | PubMed |
description | In adults, bone is the preferential target site for metastases from primary cancers of prostate, breast, lungs and thyroid. The tendency of these cancers to metastasize to bone is determined by the anatomical distribution of the blood vessels, by the genetic profile of the cancer cells and by the biological characteristics of the bone microenvironment that favour the growth of metastatic cells of certain cancers. Metastases to bone may have either an osteolytic or an ostoblastic phenotype. The interaction in the bone microenvironment between biological factors secreted by metastatic cells, and by osteoblasts and osteoclasts, and the osteolytic and osteoblastic factors released from the organic matrix mediate a vicious cycle characterized by metastatic growth and by ongoing progressive bone destruction. This interaction determines the phenotype of the metastatic bone disease. |
format | Online Article Text |
id | pubmed-3160351 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-31603512011-08-24 A short account of metastatic bone disease Feller, Liviu Kramer, Beverley Lemmer, Johan Cancer Cell Int Review In adults, bone is the preferential target site for metastases from primary cancers of prostate, breast, lungs and thyroid. The tendency of these cancers to metastasize to bone is determined by the anatomical distribution of the blood vessels, by the genetic profile of the cancer cells and by the biological characteristics of the bone microenvironment that favour the growth of metastatic cells of certain cancers. Metastases to bone may have either an osteolytic or an ostoblastic phenotype. The interaction in the bone microenvironment between biological factors secreted by metastatic cells, and by osteoblasts and osteoclasts, and the osteolytic and osteoblastic factors released from the organic matrix mediate a vicious cycle characterized by metastatic growth and by ongoing progressive bone destruction. This interaction determines the phenotype of the metastatic bone disease. BioMed Central 2011-07-27 /pmc/articles/PMC3160351/ /pubmed/21794164 http://dx.doi.org/10.1186/1475-2867-11-24 Text en Copyright ©2011 Feller et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Feller, Liviu Kramer, Beverley Lemmer, Johan A short account of metastatic bone disease |
title | A short account of metastatic bone disease |
title_full | A short account of metastatic bone disease |
title_fullStr | A short account of metastatic bone disease |
title_full_unstemmed | A short account of metastatic bone disease |
title_short | A short account of metastatic bone disease |
title_sort | short account of metastatic bone disease |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3160351/ https://www.ncbi.nlm.nih.gov/pubmed/21794164 http://dx.doi.org/10.1186/1475-2867-11-24 |
work_keys_str_mv | AT fellerliviu ashortaccountofmetastaticbonedisease AT kramerbeverley ashortaccountofmetastaticbonedisease AT lemmerjohan ashortaccountofmetastaticbonedisease AT fellerliviu shortaccountofmetastaticbonedisease AT kramerbeverley shortaccountofmetastaticbonedisease AT lemmerjohan shortaccountofmetastaticbonedisease |